Application 021424
- Type
- NDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEURONTIN | GABAPENTIN | SOLUTION; ORAL | 250MG/5ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 7d3fc163-25f0-2c61-e053-2991aa0a76e9 | 2025-05-23 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 772d9e7a-3811-455a-99e6-f2a3d0769b9b | 2025-05-13 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 1a619a14-0b63-4cba-80e7-474c9a1c90b9 | 2025-05-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 25cf6c40-a239-4dd0-9cad-28da84d285db | 2025-05-09 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 3c8dca11-78ab-45c1-8bb2-89a41ea5dfa9 | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | 41d1ead3-046e-4abf-ae0a-cb126a1f5848 | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Actavis Pharma, Inc. | 5969871e-6c71-4c37-9d63-370718ccc80c | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Cipla USA Inc. | 9e4eca9c-6a2c-4ede-a252-1a27094bf594 | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | 30a2ed14-dcda-f972-e063-6294a90a417c | 2025-04-23 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | McKesson Corporation dba Sky Packaging | 23eb133e-2f74-4219-9892-0a8e770ec032 | 2025-04-17 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Mylan Pharmaceuticals Inc. | cff7de45-148b-4e96-88fd-6052bf75b5f7 | 2025-04-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Westminster Pharmaceuticals, LLC | 3ad96553-73a4-4a9b-8a89-10a29b794ed3 | 2025-04-04 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 7fcce531-bf7c-43b6-bea9-8f0602842c53 | 2025-04-01 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 3133c863-d33b-c9d7-e063-6294a90ae898 | 2025-03-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Coupler LLC | 3133fc78-dd7a-880c-e063-6394a90a89e1 | 2025-03-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 86c93d8b-6286-44e2-93dd-f1b10a5d83da | 2025-03-10 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 87b9171b-7d00-40fa-87ff-a717740efe8a | 2025-03-02 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 64a65366-8577-48f2-9f8e-0332f126d3c1 | 2025-03-01 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 200b61d7-6e4c-923d-e063-6294a90a42cf | 2025-02-21 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01 | 2025-02-20 | Warnings, Adverse reactions | GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.